A 42-year-old woman from rural Maharashtra attends a health camp for cervical cancer screening. She is asymptomatic with no vaginal discharge or abnormal bleeding. Pap smear is performed and reports 'atypical squamous cells of undetermined significance (ASCUS)'. The screening coordinator counsels her on next steps. Which of the following represents the most appropriate management according to current screening guidelines?

Explanation

## Management of ASCUS in Cervical Cancer Screening ### Classification of Pap Smear Findings ASCUS (Atypical Squamous Cells of Undetermined Significance) is an intermediate cytologic finding that requires further evaluation but does not mandate immediate invasive procedures. ### Current Management Algorithm for ASCUS **Key Point:** ASCUS requires risk stratification to determine which patients need colposcopy versus those who can be managed with surveillance. The two accepted management pathways are: 1. **Reflex HPV testing** — If HPV-positive → colposcopy; if HPV-negative → routine screening 2. **Repeat cytology at 6 months** — If repeat smear is normal → routine screening; if abnormal → colposcopy ### Why Reflex HPV Testing is Preferred **High-Yield:** HPV testing has superior negative predictive value (~99%) for detecting cervical intraepithelial neoplasia (CIN) grade 2 or higher. HPV-negative ASCUS patients have <1% risk of underlying CIN3+ and can safely return to routine screening. ### Comparison of Management Options | Management | Rationale | Outcome | |---|---|---| | **Reflex HPV testing** | Identifies high-risk HPV strains (16, 18, 31, 33, 45) | HPV+ → colposcopy; HPV− → routine screening | | **Repeat cytology at 6 months** | Less costly, acceptable alternative in resource-limited settings | Requires patient compliance and follow-up | | **Immediate colposcopy** | Overtreatment; ~90% of ASCUS are benign | Unnecessary procedures, anxiety, cost | | **12-month repeat** | Too long; delays diagnosis in HPV+ cases | Suboptimal; not recommended | **Clinical Pearl:** In India, where HPV testing infrastructure may be limited, repeat cytology at 6 months is an acceptable alternative, but reflex HPV testing is the gold standard per WHO and IARC guidelines. ### Why Not Hysterectomy? **Warning:** Hysterectomy for ASCUS alone is inappropriate and represents gross overtreatment. ASCUS has only ~5% risk of underlying CIN2+ and <1% risk of invasive cancer. Hysterectomy is reserved for documented cervical cancer or severe dysplasia after colposcopy-guided biopsy. ### Screening Principles Applied **Mnemonic: SCREEN** - **S**ensitivity and specificity balance - **C**ost-effectiveness (reflex testing reduces unnecessary colposcopy) - **R**isk stratification (HPV status determines next step) - **E**arly detection without overdiagnosis - **E**quity of access - **N**atural history understanding (ASCUS → CIN → cancer is not inevitable) [cite:Park 26e Ch 10]